Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aziyo Biologics Inc Cl A (AZYO)

Aziyo Biologics Inc Cl A (AZYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,213
  • Shares Outstanding, K 16,250
  • Annual Sales, $ 49,190 K
  • Annual Income, $ -32,900 K
  • 60-Month Beta -0.09
  • Price/Sales 0.48
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AZYO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.25
  • Most Recent Earnings $-0.65 on 08/14/23
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +136,949.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2600 +18.25%
on 08/15/23
1.9400 -23.20%
on 08/07/23
-0.4100 (-21.58%)
since 08/04/23
3-Month
1.2600 +18.25%
on 08/15/23
2.8000 -46.79%
on 06/20/23
-0.8200 (-35.50%)
since 06/06/23
52-Week
1.1000 +35.45%
on 03/22/23
9.0100 -83.46%
on 11/03/22
-5.8200 (-79.62%)
since 09/06/22

Most Recent Stories

More News
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...

AZYO : 1.4900 (+2.05%)
SIEN : 0.1740 (-18.69%)
BIOL : 0.1480 (+2.78%)
BTCY : 1.3000 (-6.47%)
ETON : 3.12 (-2.80%)
SWKH : 17.10 (+0.53%)
Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates

Dr. Reddy's (RDY) reports better-than-expected fourth-quarter results where both earnings and revenues beat estimates.

RDY : 74.02 (+4.37%)
IMGN : 31.23 (unch)
AZYO : 1.4900 (+2.05%)
BTTX : 0.0090 (+15.38%)
Catalyst's (CPRX) Q1 Earnings Lag, Sales Boost Revenues

Catalyst (CPRX) reports mixed results for the first quarter, wherein earnings miss and revenues beat estimates. Fycompa sales boost revenues. The company maintains revenue guidance. The stock surges 3%....

IMGN : 31.23 (unch)
CPRX : 14.68 (-2.91%)
AZYO : 1.4900 (+2.05%)
BTTX : 0.0090 (+15.38%)
Why Shares of LeMaitre Vascular Are Up Wednesday

LeMaitre announced first-quarter earnings and guidance numbers.

AZYO : 1.4900 (+2.05%)
LMAT : 62.99 (-1.62%)
Aziyo Biologics, Inc. (AZYO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Aziyo Biologics, Inc. (AZYO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...

AZYO : 1.4900 (+2.05%)
ACER's Stock Down on Failure of Phase II Study, Cash Updates

ACER announces the failure of its phase IIa study of ACER-801 to treat vasomotor symptoms associated with menopause, along with its extinguishing cash runway. Stock down.

SNY : 49.36 (+5.90%)
ACER : 0.6601 (-17.95%)
AZYO : 1.4900 (+2.05%)
AVTX : 14.98 (+5.49%)
Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse

Catalyst Pharmaceuticals (CPRX) reports better-than-expected financial performance as it beats both earnings and revenue estimates. Firdapse sales continue to grow year over year.

CPRX : 14.68 (-2.91%)
RCEL : 8.30 (-3.15%)
AZYO : 1.4900 (+2.05%)
AVTX : 14.98 (+5.49%)
Aziyo Biologics, Inc. (AZYO) Upgraded to Buy: Here's What You Should Know

Aziyo Biologics, Inc. (AZYO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AZYO : 1.4900 (+2.05%)
Are Medical Stocks Lagging Bionano Genomics (BNGO) This Year?

Here is how Bionano Genomics, Inc. (BNGO) and Aziyo Biologics, Inc. (AZYO) have performed compared to their sector so far this year.

BNGO : 0.7590 (-0.28%)
AZYO : 1.4900 (+2.05%)
Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Tops Revenue Estimates

Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -10.61% and 1.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AZYO : 1.4900 (+2.05%)
EXAI : 3.99 (-3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aziyo Biologics Inc.is a regenerative medicine company. It focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. The company operates principally in Roswell, Georgia; and...

See More

Key Turning Points

3rd Resistance Point 1.6932
2nd Resistance Point 1.6165
1st Resistance Point 1.5533
Last Price 1.4900
1st Support Level 1.4134
2nd Support Level 1.3367
3rd Support Level 1.2735

See More

52-Week High 9.0100
Fibonacci 61.8% 5.9884
Fibonacci 50% 5.0550
Fibonacci 38.2% 4.1216
Last Price 1.4900
52-Week Low 1.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar